
Rituximab is a monoclonal antibody used to treat certain B-cell blood cancers and autoimmune diseases. It is administered by intravenous infusion, either alone or with other treatments, under specialist supervision and careful monitoring.
| Generic Name | Rituximab |
| Strength | 500 mg |
| Manufacturer | Eli Lilly and Company |
| Packing | 1 Vial |
| Prescribed For | Non-Hodgkin’s lymphoma and chronic lymphocytic leukemia |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




Rituximab attaches to a protein called CD20 found on the surface of B lymphocytes. This marks the targeted B cells for destruction by the immune system. Removing abnormal or overactive B cells helps treat certain blood cancers and autoimmune conditions.
Rituximab prices may vary between countries depending on the brand, strength, pack size, pharmacy, insurance coverage, government subsidies, taxes and local healthcare policies. The following resources provide country-specific pricing, reimbursement, regulatory or medicine information.